ECRM_1170x120_8-1-17

Chris Christie

President’s opioid crisis commission issues report

President’s opioid crisis commission issues report

WASHINGTON — The President’s Commission on Combating Drug Addiction and the Opioid Crisis has issued its final report, which includes 56 recommendations to the Trump administration to help fight opioid abuse. President Donald Trump formed the presidential commission, chaired by New Jersey Gov. Chris Christie (R.), in a March 29 executive order as a way

NACDS CEO discusses opioid crisis with HHS secretary

NACDS CEO discusses opioid crisis with HHS secretary

ARLINGTON, Va. — Steve Anderson, president and chief executive officer of the National Association of Chain Drug Stores, took part in a meeting on the opioid epidemic with Health and Human Services Secretary Tom Price. NACDS said that at yesterday’s meeting Price sought to learn more about pharmacy’s role in addressing abuse and misuse of

NACDS offers input to U.S. drug abuse commission

NACDS offers input to U.S. drug abuse commission

ARLINGTON, Va. — The National Association of Chain Drug Stores described retail pharmacy as a strong partner in the fight against drug abuse in a letter to New Jersey Gov. Chris Christie, chairman of the President’s Commission on Combating Drug Addiction and the Opioid Epidemic. NACDS president and chief executive officer Steve Anderson noted in

N.J. governor signs biosimilars legislation

N.J. governor signs biosimilars legislation

WASHINGTON — New Jersey Gov. Chris Christie has approved legislation to create a pathway for the substitution of interchangeable biologic drugs, drawing praise from the Biotechnology Industry Organization (BIO) and BioNJ, a state biotechnology organization. Christie signed Assembly Bill 2477 into law on Monday, following unanimous passage in the New Jersey Senate and Assembly earlier